Leading global contract research organisation, PPD, Inc. announced it has opened its global central lab facility in Singapore, strengthening its ability to provide biopharmaceutical clients an extensive range of customized laboratory services in Southeast Asia, a high-growth region for clinical research.

"Expanding our global central lab services into Singapore demonstrates our commitment to deliver high quality specimens and laboratory results for our clients in a growing biopharmaceutical market," said Steve Lobel, vice president, global laboratory operations, PPD. "We can expedite delivery of lab data through reduced transportation and shipping time at better logistics costs for our clients."

PPD also has an office in Singapore where for more than 10 years it has provided a range of clinical development services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs. The laboratory instrumentation and standards in Singapore are identical to platforms located at PPD's global central labs in Brussels, Belgium; Highland Heights, Ky.; and Beijing, China. Assays are extensively cross validated among all PPD locations to produce combinable data.